Yang (Ted) D. Teng, Ph.D., M.S., M.D., Principal Investigator
Dr. Teng directs two basic science and translational research laboratories that are affiliated with the Departments of Physical Medicine & Rehabilitation (PM&R) and Neurosurgery, Harvard Medical School/ Spaulding Rehabilitation Hospital Network/Brigham & Women’s Hospital and the Veterans Affairs Boston Healthcare System, respectively.
In addition to his initial medical training, Dr. Teng obtained his M.S. in neuropharmacology from Beijing University Health Science Center, PRC and earned his Ph.D. in Cell Biology/Neuroscience from Georgetown University, Washington DC, USA. He completed his post-doctoral training at Georgetown University and Boston Children’s Hospital/Harvard Medical School and Harvard-MIT joint research program, respectively. Dr. Teng studies Recovery Neurobiology and Functional Multipotency of Stem Cells through understanding intra-spinal cord neural circuitry reorganization and molecular mechanisms that underlie stem cell-based multimodal strategy to treat spinal cord injury (SCI), stroke, traumatic brain injury (TBI) and neural degenerative diseases. His primary research interest also includes post neurotrauma secondary mechanisms that trigger further loss of neurons and axons in the spinal cord, SCI-related respiratory, gastrointestinal and sensory abnormalities (i.e., autonomic disorders and neuropathic pain), cellular/molecular events responsible for muscular atrophy and bone degeneration resulting from spinal cord trauma, and inflammatory mechanisms in TBI and post trauma stress disorders (PTSD). The ultimate goal of Teng Laboratories is to translate the most tangible basic neuroscience and stem cell discoveries into clinical therapies following Recovery Neurobiology principles to improve function and impede major complications following SCI, TBI and other neurological disorders.
For Dr. Teng Team’s publications please go to the PI's website at Harvard Catalyst Program.